Evaluating the Response of the Immune System of People with Long COVID (post SARS-CoV-2)

NCT05131594 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-09-19

No results posted yet for this study

Summary

Many people who have had COVID 19 continue to experience symptoms long after they have recovered from the acute infection. This study will examine the clinical symptoms of people with "Long COVID" and measure various markers of inflammation in their blood.

Conditions

Sponsors & Collaborators

  • San Diego Biomedical Research Institute

    collaborator OTHER
  • Huntington Memorial Hospital

    lead OTHER

Principal Investigators

  • Kimberly Shriner, MD · Huntington Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-13
Primary Completion
2025-06-30
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05131594 on ClinicalTrials.gov